Showing results (671-680 of 843) with videos related to
Sort By:
Pageof 85
Drug and Alcohol Dependence|June 18, 2017
A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adultsKevin M Gray, Susan C Sonne, Erin A McClure, et al.Journal of Virology|August 13, 2011
Primary infection by a human immunodeficiency virus with atypical coreceptor tropismChunlai Jiang, Nicholas F Parrish, Craig B Wilen, et al.Plos Pathogens|January 5, 2017
Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization FingerprintingNicole A Doria-Rose, Han R Altae-Tran, Ryan S Roark, et al.Cell Reports|October 26, 2018
Completeness of HIV-1 Envelope Glycan Shield at Transmission Determines Neutralization BreadthKshitij Wagh, Edward F Kreider, Yingying Li, et al.Journal of Virology|May 9, 2014
HIV-1 vaccine-induced C1 and V2 Env-specific antibodies synergize for increased antiviral activitiesJustin Pollara, Mattia Bonsignori, M Anthony Moody, et al.Plos Pathogens|May 21, 2010
High Multiplicity Infection by HIV-1 in Men Who Have Sex with MenHui Li, Katharine J Bar, Shuyi Wang, et al.Plos One|April 18, 2019
Consistent elicitation of cross-clade HIV-neutralizing responses achieved in guinea pigs after fusion peptide priming by repetitive envelope trimer boostingCheng Cheng, Kai Xu, Rui Kong, et al.Cell Reports|December 13, 2018
V2-Directed Vaccine-like Antibodies from HIV-1 Infection Identify an Additional K169-Binding Light Chain Motif with Broad ADCC ActivityCharmaine van Eeden, Constantinos Kurt Wibmer, Cathrine Scheepers, et al.Science (New York, N.Y.)|July 21, 2007
A whole-genome association study of major determinants for host control of HIV-1Jacques Fellay, Kevin V Shianna, Dongliang Ge, et al.JCI Insight|March 9, 2018
Fine epitope signature of antibody neutralization breadth at the HIV-1 envelope CD4-binding siteHao D Cheng, Sebastian K Grimm, Morgan Sa Gilman, et al.Pageof 85